In this activity, you will assign a Gleason Score to some challenging tumors such as small foci, multifocal tumors and multiple adenocarcinoma variants and other carcinomas. In addition, one challenge many general pathologists face is undergrading which can lead to incorrect treatment. This activity will also focus on how to grade and report these tumors effectively in the context of needle biopsy and radical prostatectomies.
After completing this activity, you should be able to:
- Assign a Gleason score to challenging tumors including small foci tumors, multifocal tumors, and multiple adenocarcinoma variants and other carcinomas.
Accreditation: The College of American Pathologists (CAP) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
CME Category 1: The College of American Pathologists designates this internet enduring material educational activity for a
maximum of 1
AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
You must answer the assessment questions and complete the evaluation to claim credit and print your certificate.
To pay with a check, print a copy of this page and send it with your check to the address below. You will be notified when your payment has been processed and you have been registered into the activity.
College of American Pathologists
325 Waukegan Road
Northfield, IL 60093-2750
Refunds will be handled on an exception basis. Please submit your request to the CAP in writing via email at
email@example.com or fax at 847-832-8006.
Pop-up blockers must be turned off.
CAP Learning has recognized that some Veteran’s Administration, US Government, and military participants may have difficulty accessing the online assessment portion of this activity. If you experience difficulty or have any questions, please contact a representative of the CAP Learning Division at 800-323-4040 option 1 or firstname.lastname@example.org.
This activity and evaluation are available November 1, 2021, and expire October 31, 2024, at 12:00 AM (ET). You must claim credit by this date and time.